BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26089013)

  • 1. Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure.
    Pastormerlo LE; Agazio A; Benelli E; Gabutti A; Poletti R; Prontera C; Clerico A; Emdin M; Passino C
    Am J Cardiol; 2015 Aug; 116(4):567-72. PubMed ID: 26089013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
    Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Rocca HB; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Wilson Tang WH; Grodin JL; Passino C; Emdin M
    Int J Cardiol; 2019 Feb; 277():166-172. PubMed ID: 30416028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation.
    Melki D; Lind S; Agewall S; Jernberg T
    Clin Chim Acta; 2012 May; 413(9-10):933-7. PubMed ID: 22366164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry.
    Luu B; Leistner DM; Herrmann E; Seeger FH; Honold J; Fichtlscherer S; Zeiher AM; Assmus B
    Circ Res; 2017 Jun; 120(12):1938-1946. PubMed ID: 28351842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
    J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides.
    Kusumoto A; Miyata M; Kubozono T; Ikeda Y; Shinsato T; Kuwahata S; Fujita S; Takasaki K; Yuasa T; Hamasaki S; Tei C
    J Cardiol; 2012 Mar; 59(2):202-8. PubMed ID: 22266455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
    Guazzi M; Boracchi P; Labate V; Arena R; Reina G
    J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function.
    Kallistratos MS; Pavlidis AN; Chamodraka ES; Varounis C; Dritsas A; Laoutaris ID; Manolis AJ; Cokkinos DV
    Angiology; 2012 Oct; 63(7):516-21. PubMed ID: 22156406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
    Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
    Jungbauer CG; Riedlinger J; Buchner S; Birner C; Resch M; Lubnow M; Debl K; Buesing M; Huedig H; Riegger G; Luchner A
    Clin Chem Lab Med; 2011 Nov; 49(11):1899-906. PubMed ID: 21892905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
    Rørth R; Jhund PS; Kristensen SL; Desai AS; Køber L; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Eur J Heart Fail; 2019 Jan; 21(1):40-49. PubMed ID: 30537261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina.
    Ndrepepa G; Braun S; Schulz S; Fusaro M; Keta D; Pache J; Seyfarth M; Mehilli J; Schömig A; Kastrati A
    Eur J Clin Invest; 2011 Oct; 41(10):1054-62. PubMed ID: 21413976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM
    Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.